Literature DB >> 8674170

Effects of L-arginine supplementation on endothelium-dependent coronary vasodilation in patients with angina pectoris and normal coronary arteriograms.

K Egashira1, Y Hirooka, T Kuga, M Mohri, A Takeshita.   

Abstract

BACKGROUND: The pathogenesis of impaired endothelium-dependent coronary vasodilation in angina pectoris and normal coronary arteriograms (microvascular angina pectoris) is not known. We examined whether supplementation with L-arginine, a precursor of endothelium-derived nitric oxide, improves endothelium-dependent coronary vasodilation in patients with microvascular angina. METHODS AND
RESULTS: The effect of intracoronary infusion of L-arginine (50 mg/mm) on acetylcholine-induced coronary vasomotion was studied in eight patients with microvascular angina and eight control subjects. The responses of the large epicardial coronary artery diameter and coronary blood flow were measured with coronary arteriography and an intracoronary Doppler catheter, respectively. Acetylcholine increased coronary blood flow with modest vasoconstriction of the large coronary artery without altering arterial pressure and heart rate. The acetylcholine-induced increases in coronary blood flow were significantly less (P < .01) in patients than in control subjects. L-Arginine significantly augmented the coronary blood flow responses to acetylcholine in patients, but not in control subjects. L-Arginine did not alter responses of the large coronary artery in either group.
CONCLUSIONS: Study results suggest that L-arginine improved endothelium-dependent vasodilation of coronary microcirculation in patients with microvascular angina pectoris.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8674170     DOI: 10.1161/01.cir.94.2.130

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  26 in total

1.  Effect of L-arginine administration on myocardial thallium-201 perfusion during exercise in patients with angina pectoris and normal coronary angiograms.

Authors:  H Fujita; H Yamabe; M Yokoyama
Journal:  J Nucl Cardiol       Date:  2000 Mar-Apr       Impact factor: 5.952

2.  Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats.

Authors:  Kesavarao Kumar Ebenezar; Venkatachalem Sathish; Thiruvengadam Devaki
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

3.  Effects of L-arginine on flow mediated dilatation induced by atrial pacing in diseased epicardial coronary arteries.

Authors:  D Tousoulis; G J Davies; C Tentolouris; T Crake; G Goumas; C Stefanadis; P Toutouzas
Journal:  Heart       Date:  2003-05       Impact factor: 5.994

4.  Effects of vitamin C on intracoronary L-arginine dependent coronary vasodilatation in patients with stable angina.

Authors:  D Tousoulis; C Xenakis; C Tentolouris; G Davies; C Antoniades; T Crake; C Stefanadis
Journal:  Heart       Date:  2005-10       Impact factor: 5.994

5.  58-year-old patient with cardiac arrest due to coronary spasm.

Authors:  C Nalenz; D Konradi; R Blank; H-J Rupprecht
Journal:  Clin Res Cardiol       Date:  2007-08-31       Impact factor: 5.460

Review 6.  Coronary microvascular dysfunction, microvascular angina, and treatment strategies.

Authors:  Mark A Marinescu; Adrián I Löffler; Michelle Ouellette; Lavone Smith; Christopher M Kramer; Jamieson M Bourque
Journal:  JACC Cardiovasc Imaging       Date:  2015-02

Review 7.  [Therapeutic options for improvement of myocardial perfusion in coronary atherosclerosis].

Authors:  V Schächinger
Journal:  Herz       Date:  1998-03       Impact factor: 1.443

Review 8.  Antagonist molecules in the treatment of angina.

Authors:  Ashish K Gupta; David Winchester; Carl J Pepine
Journal:  Expert Opin Pharmacother       Date:  2013-09-18       Impact factor: 3.889

Review 9.  Treatment of refractory angina in patients not suitable for revascularization.

Authors:  Timothy D Henry; Daniel Satran; E Marc Jolicoeur
Journal:  Nat Rev Cardiol       Date:  2013-12-24       Impact factor: 32.419

10.  Serum ADMA concentration-- an independent factor determining FMD impairment in cardiac syndrome X.

Authors:  Maciej Haberka; Katarzyna Mizia-Stec; Zbigniew Gasior; Magdalena Mizia; Joanna Janowska; Michał Holecki; Barbara Zahorska-Markiewicz
Journal:  Ups J Med Sci       Date:  2009       Impact factor: 2.384

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.